We are live on ! Find out more
Daiwa Securities Group

Daiwa Securities Group Portfolio holdings

AUM $34.8B
1-Year Est. Return 20.7%
This Fund
S&P 500
This Quarter Est. Return
+14.31%
1 Year Est. Return
+20.7%
3 Year Est. Return
+66.64%
5 Year Est. Return
+79.21%
10 Year Est. Return
+192.59%
AUM
$16.1B
AUM Growth
+$2.04B
Cap. Flow
-$98.3M
Cap. Flow %
-0.61%
Top 10 Hldgs %
35.04%
Holding
1,426
New
99
Increased
660
Reduced
349
Closed
106

Top Buys

Rank Stock Value
1
IRM icon
Iron Mountain
IRM
+$97M
2
VICI icon
VICI Properties
VICI
+$80.3M
3
ESS icon
Essex Property Trust
ESS
+$78.8M
4
WPC icon
W.P. Carey
WPC
+$61.7M
5
IBN icon
ICICI Bank
IBN
+$28M

Sector Composition

Rank Sector Weight
1 Real Estate 52.1%
2 Technology 13.53%
3 Consumer Discretionary 4.91%
4 Financials 4.82%
5 Healthcare 4.53%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CGEM icon
1276
Cullinan Oncology
CGEM
$1.07B
$1K ﹤0.01%
127
CHRS icon
1277
Coherus Oncology
CHRS
$222M
$1K ﹤0.01%
262
CRBU icon
1278
Caribou Biosciences
CRBU
$148M
$1K ﹤0.01%
176
ERAS icon
1279
Erasca
ERAS
$6.3B
$1K ﹤0.01%
354
FULC icon
1280
Fulcrum Therapeutics
FULC
$248M
$1K ﹤0.01%
138
HALO icon
1281
PUT
Halozyme
HALO
$9.9B
$1K ﹤0.01%
+21
New +$791
HROW icon
1282
Harrow
HROW
$1.47B
$1K ﹤0.01%
110
HUMA icon
1283
Humacyte
HUMA
$170M
$1K ﹤0.01%
301
ITOS
1284
DELISTED
iTeos Therapeutics
ITOS
$1K ﹤0.01%
121
LXRX icon
1285
Lexicon Pharmaceuticals
LXRX
$1.04B
$1K ﹤0.01%
434
MGTX icon
1286
MeiraGTx Holdings
MGTX
$1.09B
$1K ﹤0.01%
130
MXCT icon
1287
MaxCyte
MXCT
$112M
$1K ﹤0.01%
293
NAUT icon
1288
Nautilus Biotechnolgy
NAUT
$152M
$1K ﹤0.01%
362
NVAX icon
1289
Novavax
NVAX
$1.21B
$1K ﹤0.01%
291
OCUL icon
1290
Ocular Therapeutix
OCUL
$1.85B
$1K ﹤0.01%
262
PGEN icon
1291
Precigen
PGEN
$1.97B
$1K ﹤0.01%
708
QURE icon
1292
uniQure
QURE
$2.52B
$1K ﹤0.01%
158
SIRI icon
1293
CALL
SiriusXM
SIRI
$10.7B
$1K ﹤0.01%
+10
New +$480
TERN
1294
DELISTED
Terns Pharmaceuticals
TERN
$1K ﹤0.01%
151
URGN icon
1295
UroGen Pharma
URGN
$1.99B
$1K ﹤0.01%
48
VNDA icon
1296
Vanda Pharmaceuticals
VNDA
$310M
$1K ﹤0.01%
191
VTYX
1297
DELISTED
Ventyx Biosciences
VTYX
$1K ﹤0.01%
228
XERS icon
1298
Xeris Biopharma Holdings
XERS
$1.42B
$1K ﹤0.01%
404
ME
1299
DELISTED
23andMe Holding Co
ME
$1K ﹤0.01%
48
-1,868
-97% -$32.3K
MRNS
1300
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
$1K ﹤0.01%
58

Similar funds

Daiwa Securities Group's Q4 2023 Portfolio in Review

As of Q4 2023, Daiwa Securities Group held 1,426 positions worth $16.1B, up 15% from $14B the previous quarter. Its ten largest holdings account for 35% of the portfolio.

Daiwa Securities Group's Q4 2023 filing shows 99 new, 660 increased, 349 reduced and 106 closed positions. Its largest new stake was Veralto: 45,224 shares worth $3.72M. The largest sale was Mid-America Apartment Communities, an estimated $128M.

By sector, the portfolio is most concentrated in Real Estate at 52% of assets, down from 53% a quarter earlier, followed by Technology and Consumer Discretionary.

  • Daiwa Securities Group's largest Q4 2023 buy was Veralto: 45,224 shares worth $3.72M.
  • Daiwa Securities Group added most to Iron Mountain in Q4 2023, an estimated $97M increase.
  • Daiwa Securities Group's biggest Q4 2023 reduction was Mid-America Apartment Communities, cutting an estimated $128M.
  • Daiwa Securities Group fully exited Activision Blizzard in Q4 2023, selling an estimated $6.04M.
  • Daiwa Securities Group's ten largest holdings make up 35% of its $16.1B portfolio in Q4 2023.
  • Daiwa Securities Group opened 99 new positions and closed 106 in Q4 2023.
  • Daiwa Securities Group's portfolio value rose 15% quarter-over-quarter to $16.1B.

Based on Daiwa Securities Group's 13F filing for Q4 2023, filed 31 Jan 2024.